
|Articles|July 1, 2004
Phase III study eyes intravitreal therapy for exudative AMD
Anti-VEGF monoclonal antibody fragment improves vision, reduce fluorescein angiographic leakage
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement


















































.png)


